Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2026-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$188.7m
reported value
-13.4% vs Q4 2025
37positions
59.8%in top 10
8 new
3 added
3 reduced
4 sold out
vs Q4 2025
Holdings, Q1 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $19.7m10.44% | Unchanged |
| SPROTT PHYSICAL GOLD TR PHYS | $13.7m7.27% | New |
| ROYAL GOLD INC RGLD | $13.4m7.11% | Unchanged |
| MEIRAGTX HLDGS PLC MGTX | $10.8m5.74% | Unchanged |
| AGNICO EAGLE MINES LTD AEM | $10.7m5.67% | Unchanged |
| KINROSS GOLD CORP KGC | $9.8m5.18% | Reduced -90.0k |
| ALDEYRA THERAPEUTICS INC ALDX | $9.3m4.90% | Unchanged |
| SEABRIDGE GOLD INC COM | $9.0m4.76% | Unchanged |
| OR ROYALTIES INC. OR | $8.6m4.53% | New |
| FRANCO NEV CORP FNV | $7.9m4.19% | Added +7.0k |
| SSR MINING IN SSRM | $7.2m3.82% | Unchanged |
| ELICIO THERAPEUTICS INC ELTX | $6.7m3.57% | Unchanged |
| ENTERA BIO LTD ENTX | $6.5m3.43% | Unchanged |
| NUVATION BIO INC NUVB | $6.4m3.41% | Unchanged |
| CENTERRA GOLD INC CGAU | $6.4m3.38% | Reduced -138.4k |
| PAN AMERN SILVER CORP PAAS | $5.5m2.90% | Unchanged |
| SPROTT PHYSICAL SILVER TR PSLV | $5.4m2.87% | New |
| OCULAR THERAPEUTIX INC OCUL | $5.1m2.69% | Unchanged |
| TRIPLE FLAG PRECIOUS METAL TFPM | $4.0m2.12% | Added +56.2k |
| GOLD ROYALTY CORP GROY | $3.6m1.90% | New |
| ALAMOS GOLD INC NEW AGI | $2.2m1.18% | Unchanged |
| ABEONA THERAPEUTICS INC ABEO | $2.2m1.15% | Added +249.6k |
| NEW PAC METALS CORP NEWP | $2.0m1.06% | Unchanged |
| COEUR MNG INC CDE | $1.8m0.96% | Unchanged |
| ISHARES TR ITA | $1.7m0.89% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.7m0.88% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $1.6m0.87% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.5m0.78% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.0m0.54% | Unchanged |
| ELEMENTAL RTY CORP ELE | $943.0k0.50% | New |
| VERSAMET ROYALTIES CORP VMET | $633.6k0.34% | New |
| DAKOTA GOLD CORP DC | $620.8k0.33% | Unchanged |
| AMRIZE LTD AMRZ | $514.0k0.27% | New |
| ALTIMMUNE INC ALT | $492.8k0.26% | Reduced -961.5k |
| CARDIOL THERAPEUTICS INC CRDL | $135.0k0.07% | Unchanged |
| PHARMING GROUP NV PHAR | $67.5k0.04% | New |
| Orgenesis, Inc. COM | $30.4k0.02% | Unchanged |
Sold out since Q4 2025
| Security | Value then |
|---|---|
| AVADEL PHARMACEUTICALS PLC | $12.9m600.0k shares |
| SPDR GOLD TR GLD | $12.7m32.0k shares |
| ISHARES SILVER TR SLV | $5.2m80.0k shares |
| APPLIED THERAPEUTICS INC APLT | $605.0k6.0m shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |